Mainstream

Fate Therapeutics GAAP EPS of -$0.32 beats by $0.07, revenue of $1.63M beats by $0.45M

Fate Therapeutics GAAP EPS of -$0.32 beats by $0.07, revenue of $1.63M beats by $0.45M

Post ContentfateRead More

You might also be interested in reading UnitedHealth drops as CEO steps down; suspends guidance.

May 13, 2025
In Mainstream